Skip to main content

Johnson & Johnson

JNJ
Exchange
NYSE
Industry
Pharmaceutical Preparations
SEC CIK
0000200406

In the last 90 days, Johnson & Johnson insiders filed 0 open-market purchases and 6 sales; 4,699 institutions reported holding it in 13F filings for Q2 2026, worth $456.9B in total; 5 superinvestors hold it, including Markel Group and Fairfax Financial.

Open-market trades, last 90 days

Open-market purchases (P) and sales (S) by Johnson & Johnson insiders, counted by Form 4 filing. Trades with a flagged price and duplicate filings are left out.

Open-market buys
0 filings
Open-market sells
6 filings
5 insiders, $67.8M in total
Insiders trading
5
Net value
−$67.8M
Purchases minus sales

Insider roster

Directors, officers and 10% owners who have filed a Form 4 for Johnson & Johnson, current and former, most recent filer first. Last reported holding is the position after the last non-derivative trade in their latest filing.

Insider roster for Johnson & Johnson
NameTitleLast reported holdingLast filingFilings, past year
Pinto Daniel EDirector–Sep 10, 20265
Woods Eugene A.Director–Sep 10, 20265
Hewson Marillyn ADirector–Sep 10, 20265
Schmid TimothyEVP, WW Chair, MedTech25,447Sep 4, 20265
Taubert Jennifer LEVP, WWC. Innovative Medicine194,451Aug 18, 20263
Duato JoaquinCEO and Chairman of the Board275,967Aug 14, 20265
Forminard ElizabethEVP, Chief Legal Officer16,994Aug 7, 20264
Broadhurst VanessaEVP, Global Corp Affairs23,003Jul 21, 20263
Wengel Kathryn EEVP, Chief TO and Risk Officer114,288Jun 12, 20264
Reed John CEVP, Innovative Medicine, R&D24,911May 4, 20263
Morikis John GDirector1,849Apr 27, 20262
Johnson Paula ADirector–Apr 27, 20261
Joly HubertDirector–Apr 27, 20261
Beckerle Mary CDirector–Apr 27, 20261
McClellan Mark B.Director–Apr 27, 20261
Doudna Jennifer ADirector–Apr 27, 20261
Weinberger Mark ADirector1,000Apr 27, 20261
West NadjaDirector–Apr 27, 20261
Decker Robert JVP Corporate Controller23,682Mar 3, 20263
Wolk Joseph JExec VP, CFO14,000Feb 18, 20262
Swanson James D.EVP, CIO25,698Feb 18, 20262
Mulholland KristenEVP, Chief HR Officer19,830Feb 18, 20263
Davis D ScottDirector–Oct 15, 20240
Mulcahy Anne MDirector–Apr 29, 20240
Adamczyk DariusDirector–Apr 29, 20240
Fasolo PeterExec VP, Chief HR Officer112,076Feb 20, 20240
Hait WilliamEVP, Chief EI and Med Officer38,647Feb 20, 20240
McEvoy AshleyEVP, WW Chair, MedTech52,038Aug 25, 20230
Washington A. EugeneDirector–Mar 9, 20230
Mongon ThibautExec VP, WW Chair, Cons Health65,915Feb 15, 20230
Gorsky AlexDirector766,584Jan 18, 20230
Williams Ronald ADirector–Feb 17, 20220
Prince CharlesDirector–Feb 17, 20220
Mammen MathaiEVP, Pharm, R&D41,934Feb 17, 20220
Davis IanDirector–Feb 17, 20220
Ullmann Michael HExec VP, General Counsel158,835Feb 17, 20220

Insider trades

Each row adds up one type of transaction in one Form 4 filing. Only open-market purchases (P) and sales (S) are shown by default; use the filters to see grants, option exercises and other codes.

Insider trades
Filed (ET)Trade dateFiling delayInsiderTransactionSharesAvg priceValueHolding changeFlags
Dec 9, 2021 (view filing)Dec 72 daysDecker Robert JController, CAOSSale−5.00K$163.21−$816.0K−26.0%14.2K after
Mar 17, 2022 (view filing)Mar 152 daysDecker Robert JController, CAOSSale−5.00K$175.51−$877.5K−24.4%15.5K after3 lots
Mar 21, 2022 (view filing)Mar 174 daysMongon ThibautExec VP, WW Chair, ConsumerSSale−10.9K$176.26−$1.92M−14.6%63.8K after28 lots
Mar 21, 2022 (view filing)Mar 174 daysMongon ThibautExec VP, WW Chair, ConsumerSSale−23.7K$176.25−$4.17M−37.1%40.1K after9 lots
Apr 25, 2022 (view filing)Apr 214 daysHait WilliamSee RemarksSSale−29.7K$183.58−$5.45M−27.0%80.2K after8 lots
May 31, 2022 (view filing)May 265 daysDecker Robert JController, CAOSSale−8.46K$180.00−$1.52M−35.4%15.5K after
Jun 14, 2022 (view filing)Jun 104 daysWengel Kathryn EEVP, Chief GSC OfficerSSale−40.0K$173.00−$6.92M−35.9%71.3K after4 lots
Oct 21, 2022 (view filing)Oct 192 daysFasolo PeterExec VP, Chief HR OfficerSSale−3.61K$164.50−$594.3K−2.0%181.2K after29 lots
Oct 21, 2022 (view filing)Oct 192 daysFasolo PeterExec VP, Chief HR OfficerSSale−13.7K$164.50−$2.25M−7.6%167.5K after30 lots
Oct 21, 2022 (view filing)Oct 192 daysFasolo PeterExec VP, Chief HR OfficerSSale−29.9K$164.50−$4.93M−18.0%136.2K after30 lots
Oct 21, 2022 (view filing)Oct 192 daysFasolo PeterExec VP, Chief HR OfficerSSale−22.9K$164.50−$3.76M−16.6%114.7K after14 lots
Oct 26, 2022 (view filing)Oct 242 daysHait WilliamSee RemarksSSale−15.0K$171.55−$2.57M−15.8%80.2K after2 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−2.81K$171.02−$481.4K−1.5%189.8K after29 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−4.26K$171.13−$729.5K−2.3%184.9K after30 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−8.26K$171.14−$1.41M−4.4%179.9K after30 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−13.0K$171.22−$2.23M−7.3%164.8K after30 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−20.9K$171.19−$3.57M−12.7%144.0K after30 lots
Oct 26, 2022 (view filing)Oct 242 daysFasolo PeterExec VP, Chief HR OfficerSSale−29.3K$171.36−$5.02M−20.3%114.7K after25 lots
Nov 8, 2022 (view filing)Nov 44 daysMongon ThibautExec VP, WW Chair, ConsumerSSale−35.2K$171.18−$6.03M−46.8%40.1K after2 lots
Nov 10, 2022 (view filing)Nov 91 dayWengel Kathryn EEVP, Chief GSC OfficerSSale−16.4K$173.42−$2.85M−18.7%71.3K after
Nov 21, 2022 (view filing)Nov 183 daysDecker Robert JController, CAOSSale−16.9K$175.00−$2.96M−52.2%15.5K after
Nov 23, 2022 (view filing)Nov 221 dayTaubert Jennifer LEVP, WW Chair, PharmaceuticalsSSale−76.9K$176.78−$13.6M−37.8%126.5K after
Dec 2, 2022 (view filing)Nov 302 daysMcEvoy AshleyEVP, WW Chair, MedTechSSale−73.3K$175.47−$12.9M−63.7%41.8K after2 lots
Dec 15, 2022 (view filing)Dec 132 daysWolk Joseph JExec VP, CFOSSale−14.8K$179.60−$2.65M−29.2%35.8K after2 lots
Mar 8, 2023 (view filing)Mar 62 daysSwanson James D.See RemarksSSale−1.06K$154.66−$164.2K−10.3%9.22K after
Jun 14, 2023 (view filing)Jun 122 daysWengel Kathryn EEVP, Chief TO and Risk OfficerSSale−12.5K$160.00−$1.99M−15.9%65.9K after
Jul 27, 2023 (view filing)Jul 261 dayHait WilliamSee RemarksSSale−14.7K$172.00−$2.53M−14.3%87.7K after
Jul 27, 2023 (view filing)Jul 252 daysFasolo PeterExec VP, Chief HR OfficerSSale−20.0K$170.32−$3.41M−16.3%102.7K after
Feb 12, 2024 (view filing)Feb 93 daysTaubert Jennifer LEVP, WW Chair, PharmaceuticalsSSale−59.4K$156.27−$9.28M−29.6%141.4K after
Mar 13, 2024 (view filing)Mar 13Same dayBroadhurst VanessaEVP, Global Corp AffairsSSale−8.89K$162.16−$1.44M−37.1%15.0K after
Sep 3, 2024 (view filing)Aug 304 daysDecker Robert JVP Corporate ControllerSSale−5.63K$165.06−$930.1K−22.9%19.0K after
Dec 12, 2024 (view filing)Dec 12Same dayWeinberger Mark ADirectorPPurchase+1.00K$147.22+$147.2KNew position1.00K after
Feb 11, 2025 (view filing)Feb 74 daysWolk Joseph JExec VP, CFOSSale−13.0K$153.89−$2.00M−100.0%0 after
Feb 18, 2025 (view filing)Feb 18Same daySchmid TimothyEVP, WW Chair, MedTechSSale−403$156.15−$62.9K−2.6%15.1K after
Feb 26, 2025 (view filing)Feb 251 dayDecker Robert JVP Corporate ControllerSSale−7.00K$165.88−$1.16M−25.0%21.0K after
Jul 18, 2025 (view filing)Jul 171 dayReed John CEVP, Innovative Medicine, R&DSSale−19.1K$163.55−$3.13M−64.2%10.7K after
Aug 18, 2025 (view filing)Aug 153 daysWolk Joseph JExec VP, CFOSSale−16.8K$176.91−$2.98M−54.6%14.0K after
Aug 25, 2025 (view filing)Aug 223 daysDuato JoaquinCEO and Chairman of the BoardSSale−125.8K$179.21−$22.5M−31.3%276.0K after
Sep 5, 2025 (view filing)Sep 41 dayTaubert Jennifer LEVP, WWC. Innovative MedicineSSale−56.5K$177.81−$10.0M−24.1%178.0K after
Oct 20, 2025 (view filing)Oct 173 daysReed John CEVP, Innovative Medicine, R&DSSale−21.7K$192.71−$4.19M−67.1%10.7K after
Dec 1, 2025 (view filing)Nov 265 daysMorikis John GDirectorPPurchase+1.25K$206.15+$257.7K+208.9%1.85K after
Jan 28, 2026 (view filing)Jan 262 daysDuato JoaquinCEO and Chairman of the BoardSSale−100.0K$221.23−$22.1M−76.4%30.9K after2 lots
Feb 18, 2026 (view filing)Feb 171 dayBroadhurst VanessaEVP, Global Corp AffairsSSale−6.20K$243.39−$1.51M−21.2%23.0K after
Feb 18, 2026 (view filing)Feb 18Same daySchmid TimothyEVP, WW Chair, MedTechSSale−22.6K$244.33−$5.53M−45.8%26.8K after2 lots
Feb 18, 2026 (view filing)Feb 171 dayReed John CEVP, Innovative Medicine, R&DSSale−53.9K$243.00−$13.1M−83.5%10.7K after3 lots
Feb 18, 2026 (view filing)Feb 171 dayWolk Joseph JExec VP, CFOSSale−89.7K$242.80−$21.8M−86.5%14.0K after4 lots
Feb 18, 2026 (view filing)Feb 13-175 daysSwanson James D.EVP, CIOSSale−62.1K$243.39−$15.1M−70.7%25.7K after3 lots
Feb 23, 2026 (view filing)Feb 203 daysSchmid TimothyEVP, WW Chair, MedTechSSale−1.32K$245.66−$324.8K−4.9%25.4K after
Mar 3, 2026 (view filing)Feb 274 daysDecker Robert JVP Corporate ControllerSSale−4.08K$247.87−$1.01M−14.7%23.7K after
Jun 12, 2026 (view filing)Jun 111 dayWengel Kathryn EEVP, Chief TO and Risk OfficerSSale−10.0K$241.15−$2.41M−8.0%114.3K after